Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02611713 · ClinicalTrials.gov registry record
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
A clinical trial, sponsored by AbbVie.
- Completed
- Registry status
- 213
- Enrollment target
NCT02611713 is a clinical trial that has completed, run by AbbVie. The registered enrollment target is 213 participants.
The verdict
NCT02611713 has completed, sponsored by AbbVie.
- COMPLETED
- Registry status
- 213 participants
- Enrollment target
Study Summary
This study is a non-interventional post-marketing observational study (PMOS) of participants with advanced Parkinson's disease (PD) treated with Duodopa/Duopa in a routine clinical setting. Effectiveness of treatment will be collected with physician and participant/caregiver health outcomes beginning with PMOS enrollment (baseline visit), at the start of Duodopa/Duopa treatment via percutaneous endoscopic gastrostomy-with jejunal extension (PEG-J), at regularly scheduled visits closest to Months 3 and 6, and every 6 months thereafter up to 36 months. An additional cohort of participants will be enrolled who in addition will be evaluated with a wearable device.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2016-01-04 |
| Est. Completion | 2020-12-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02611713
The ClinicalTrials.gov registry entry for NCT02611713 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie, which has 526 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02611713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02611713 about?
NCT02611713 is a clinical study titled "Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease". This study is a non-interventional post-marketing observational study (PMOS) of participants with advanced Parkinson's disease (PD) treated with Duodopa/Duopa in a routine clinical setting. Effectiveness of treatment will be collected with physician and participant/caregiver health outcomes beginnin...
What is the current status of trial NCT02611713?
This trial is currently completed. The enrollment target is 213 participants. The study started on 2016-01-04. Estimated completion is 2020-12-24.
Who is sponsoring clinical trial NCT02611713?
This trial is sponsored by AbbVie, which has 526 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.